Results 161 to 170 of about 88,868 (230)

Impact of Delivery Mode on Neonatal Outcomes in Extremely Preterm Infants Born at 22 + 0 to 25 + 6 Weeks of Gestation. [PDF]

Medicina (Kaunas)
Markfeld-Erol F, Kuntz M, Laufs V, Tippmann S, Juhasz-Böss I, Hasenburg A, Steetskamp J.   +6 more
europepmc   +1 more source

Racial/ethnic disparities and human milk use in necrotizing enterocolitis

, 2020
Gregory P. Goldstein, Vidya V. Pai, Jessica Liu, Krista Sigurdson, Lelis B. Vernon, Henry Lee, Karl G. Sylvester, Gary M. Shaw, Jochen Profit   +8 more
openalex   +2 more sources

Cow's milk protein allergy with protein‐losing enteropathy under the scope

JPGN Reports, Volume 6, Issue 4, Page 342-350, November 2025.
ABSTRACT Objectives Cow's milk protein allergy (CMPA) is very frequent in infants. Presentation is variable, and symptoms fluctuate in intensity. Diagnosis can be challenging as it is mostly clinical. In severe cases, patients can present with anasarca secondary to protein‐losing enteropathy (PLE).
Morgane Thorens‐Borgeat, Géraldine Blanchard‐Rohner, Salim Ramadan, Jean‐Christophe Caubet, Laetitia‐Marie Petit, Valerie McLin, Anne‐Laure Rougemont   +6 more
wiley   +1 more source

Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review. [PDF]

Acta Oncol
Ekedahl H, Sigurjonsdottir G, Bergqvist V, Båtshake B, Carneiro A, Marsal J.   +5 more
europepmc   +1 more source

"Peeling paint" dermatosis in a leukemia patient. [PDF]

, 2020
Jerkins, James, Juhasz, Margit, Laquer, Vivian, Smith, Janellen   +3 more
core  

Delayed presentation of a retained colonic segment in a child with intestinal failure on teduglutide

JPGN Reports, Volume 6, Issue 4, Page 412-415, November 2025.
Abstract Teduglutide is a glucagon‐like peptide 2 (GLP‐2) analogue that was approved by the United States Food and Drug Administration for the treatment of pediatric (>1 year) intestinal failure due to short bowel syndrome in 2019. GLP‐2 analogues promote rapid intestinal adaptation, increasing the absorptive capacity of residual intestine after ...
Rachel C. Bordelon, Sarah J. Varalla, Varaha S. Tammisetti, Mohamed M. Shahin, Amanda Tchakarov, Essam Imseis, Allison L. Speer   +6 more
wiley   +1 more source

Relief of Suspected IgA Vasculitis-Associated Enterocolitis Manifested as Severe Diarrhea and Hypoalbuminemia Treated With Glucocorticoid Therapy and Administration of Fibrogammin® (Purified Coagulation Factor XIII Concentrate): A Case Report. [PDF]

Cureus
Aikawa T, Negishi T, Iida T.
europepmc   +1 more source

Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: Pathogenesis and therapeutic implications

, 2009
Kwong Leung Chan, Kwong F. Wong, John M. Luk   +2 more
openalex   +2 more sources

Portal venous gas: A benign finding in pyloric stenosis?

JPGN Reports, Volume 6, Issue 4, Page 423-426, November 2025.
Abstract Pyloric stenosis is a condition of infancy characterized by hypertrophy of the pylorus, which can progress to significant narrowing and near‐obstruction of the gastric outlet. We describe a case of a patient with pyloric stenosis who was incidentally found to have portal venous gas on ultrasound.
Kelci Butler, Tiffany Patton
wiley   +1 more source

Effect of serum creatinine changes on surgical timing and prognosis in progressive necrotizing Enterocolitis. [PDF]

BMC Pediatr
Han J, Cao J, Liu G, Duan L, Yu M, Li G, Huang L.   +6 more
europepmc   +1 more source